DXP Enterprises Inc
F:DX7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
DXP Enterprises Inc
F:DX7
|
US |
|
Aptose Biosciences Inc
OTC:APTOF
|
CA |
|
W
|
Wix.Com Ltd
F:W1X
|
IL |
|
A
|
Ameriprise Financial Inc
F:A4S
|
US |
|
Aurora Cannabis Inc
F:21P
|
CA |
|
E
|
EDP Renovaveis SA
XMUN:EDW
|
ES |
Wall St Price Targets
DX7 Price Targets Summary
DXP Enterprises Inc
According to Wall Street analysts, the average 1-year price target for DX7 is 101.98 EUR with a low forecast of 78.04 EUR and a high forecast of 118.01 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DX7's stock price target?
Price Target
101.98
EUR
According to Wall Street analysts, the average 1-year price target for DX7 is 101.98 EUR with a low forecast of 78.04 EUR and a high forecast of 118.01 EUR.
What is the Revenue forecast for DXP Enterprises Inc?
Projected CAGR
12%
Over the last 14 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 3 years is 12%.
What is the Operating Income forecast for DXP Enterprises Inc?
Projected CAGR
21%
Over the last 14 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 3 years is 21%.
What is the Net Income forecast for DXP Enterprises Inc?
Projected CAGR
23%
Over the last 14 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 3 years is 23%.
